
Sanofi is exploring a $35B–$43B takeover of Insmed and its blockbuster lung drug Brinsupri as the French pharma giant braces for Dupixent’s looming patent expiration.
CBI's 4th Bio/Pharmaceutical Product Launch Summit runs in Cambridge, MA, on September 25-26. This year's speakers-including Jasmine Daniel, Direcor, US Patient Services at Shire and Diana Dai, Executive Director, US Pipeline and Launch Management at Sandoz-will shine a light on identifying keys to early commercialization and ensuring post-launch success.
You can receive a $200 discount off this event's registration rate by completing this very short survey:
(Discount expires August 31, 2018).





